Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
Jan 30, 2026, 2:42 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 36.73 million as of January 29, 2026. Its market cap has increased by 286.36% in one year.
Market Cap
36.73M
Enterprise Value
30.86M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has decreased from 39.36M to 36.73M, a decrease of -6.66%. That is a compound annual growth rate of -0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 36.73M | 11.11% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 81.52M |
| Cynata Therapeutics | 80.99M |
| Amplia Therapeutics | 71.83M |
| Neurizon Therapeutics | 56.59M |
| Entropy Neurodynamics | 51.57M |
| NeuroScientific Biopharmaceuticals | 49.89M |
| Algorae Pharmaceuticals | 37.15M |
| Argenica Therapeutics | 32.76M |